Atlas Trials

Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder

Clinical trial NCT01133301 · COMPLETED

Trial details

NCT number
NCT01133301
Sponsor
Central Institute of Mental Health, Mannheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Borderline Personality DisorderDissociation
Start date
1998-08-01
Primary completion
2001-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.